Skip to content
AwardedSVKGoods€505,275

Antineoplastické a imunomodulačné činidlá

Published
Published 22 January 2025
Deadline
Closed 21 February 2025

Overview

Časť 1 Trastuzumab deruxtekan plc ifc 1x100 mg (liek.inj.skl. jantár.) 110 Časť 2 Daratumumab sol inj 1x15 ml/1800 mg (liek.inj.skl.) 90

Key details

Country
SVK
Status
Awarded
Category
Goods
Estimated value
€505,275
Procedure
Open
SME suitable
Yes
Published
22 January 2025
Deadline
Closed
Classification (CPV)
Antineoplastic and immunomodulating agents

Award outcome

Awarded value
€373,783
Award date
22 April 2025
Contract period
— → 17 April 2026
Winner
  • MED - ART, spol. s r.o.

Contract ending soon? Skim tracks incumbents and flags recompetes early. Book a demo to set up alerts.

Notice history

Every published notice in this contracting process, newest first.

  1. Contract Award Notice

    25 April 2025

  2. Contract Notice

    22 January 2025

Contracting authority

  • Fakultná nemocnica s poliklinikou Žilina

    Procuring entity

    Žilina, SVK

Get the full picture

AI analysis, bid scoring, and expert strategy for this tender

Skim analyses every tender against your company profile and tells you whether to bid, how to win, and who you are up against.

See which competitors are winning the contracts you're chasing.

15-minute call. We'll pull the win data on your real pipeline and show you what Skim does with it.

Awarded: Antineoplastické a imunomodulačné činidlá — won by MED - ART, spol. s r.o. — Skim